Recursion Pharmaceuticals (RXRX) is a clinical-stage biotechnology company utilizing artificial intelligence to expedite drug ...

The ability to probe the smallest building blocks of matter has long fascinated scientists, fueling advancements in medicine, ...

We recently compiled a list of the 11 AI News and Ratings You Shouldn’t Miss. In this article, we are going to take a look at ...

New research using publicly-shared DNA barcodes and citizen science images have provided new evidence on the establishment and spread of a biological control agent used for the control of the major ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

LinkedIn founder and venture capitalist Reid Hoffman has just launched drug discovery startup Manas AI, alongside Dr.

As discussed below, discovery efforts ... challenge for the development of peptidomimetic compounds that have the pharmacokinetic characteristics needed to be suitable as a drug.

The potential of AI-powered drug discovery is huge ... This could lead to faster drug development, cheaper costs, and new cures. Yet discovering the drugs is merely one step in the process.